
|Articles|October 23, 2019
Monitoring of transdermal drug delivery in skin using the Renishaw Biological Analyser
Author(s)Renishaw, Inc.
Detecting the presence and depth of penetration of drug compounds in skin can prove challenging, current technologies fail to achieve adequate penetration through layers of dermal tissue. In this study, Raman spectroscopy using the Renishaw Biological Analyser - RA816 confirmed the presence of a topical compound in the epidermis and reticular dermis with high specificity and sensitivity.
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
4
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
5
